Form-deprivation myopia in chick induces limited changes in retinal gene expression

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 8, 2007, Pages 3430-3436

  McGlinn, Alice M ^a   Baldwin, Donald A ^b   Tobias, John W ^b   Budak, Murat T ^b   Khurana, Tejvir S ^b   Stone, Richard A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CONNECTIVE TISSUE GROWTH FACTOR; ENDOTHELIN B RECEPTOR; INTERLEUKIN 18; MITOGEN ACTIVATED PROTEIN KINASE 1; TRANSCRIPTOME;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHICK; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; MYOPIA; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; AGE; ANIMAL; CHICKEN; EYE PROTECTIVE DEVICE; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; GROWTH, DEVELOPMENT AND AGING; PATHOPHYSIOLOGY; PATTERN RECOGNITION; PERCEPTION DISORDER; PHYSIOLOGY; RETINA; SIGNAL TRANSDUCTION;

AGE FACTORS; ANIMALS; CHICKENS; EYE PROTECTIVE DEVICES; FORM PERCEPTION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOMICS; MYOPIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERCEPTUAL DISTORTION; RETINA; SIGNAL TRANSDUCTION;

EID: 34648825542     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-1538     Document Type: Article

References (72)

1. Wallman J. Retinal control of eye growth and refraction. Prog Retin Eye Res. 1993;12:133-153.
2. Stone RA. Neural mechanisms and eye growth control. In: Tokoro T, ed. Myopia Updates: Proceedings of the 6th International Conference on Myopia. Tokyo: Springer; 1997;241-254.
3. Wallman J, Winawer J. Homeostasis of eye growth and the question of myopia. Neuron. 2004;43:447-468.
4. Stone RA. Myopia pharmacology: etiologic clues, therapeutic potential. In: Yorio T, Clark A, Wax M, eds. Ocular Therapeutics: an Eye on New Discoveries. New York: Elsevier/Academic Press. In press.
5. Papastergiou GI, Schmid GF, Laties AM, Pendrak K, Lin T, Stone RA. Induction of axial eye elongation and myopic refractive shift in one-year-old chickens. Vision Res. 1998;38:1883-1888.
6. Stone RA, Lin T, Laties AM. Muscarinic antagonist effects on experimental chick myopia. Exp Eye Res. 1991;52:755-758.
7. Siatkowski RM, Cotter S, Miller JM, et al. Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia. Arch Ophthalmol. 2004;122:1667-1674.
8. Tan DTH, Lam DS, Chua WH, Shu-Ping DF, Crockett RS, the Asian Pirenzepine Study Group. One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. Ophthalmology. 2005;112:84-91.
9. Stone RA, Wilson LB, Ying G-s, et al. Associations between childhood refraction and parental smoking. Invest Ophthalmol Vis Sci. 2006;47:4277-4287.
10. Wildsoet C, Wallman J. Choroidal and scleral mechanisms of compensation for spectacle lenses in chicks. Vision Res. 1995;35:1175-1194.
11. Stone RA, Liu J, Sugimoto R, Capehart C, Zhu X, Pendrak K. GABA, experimental myopia and ocular growth in chick. Invest Ophthalmol Vis Sci. 2003;44:3933-3946.
12. Kee C-s, Marzani D, Wallman J. Differences in time course and visual requirements of ocular responses to lenses and diffusers. Invest Ophthalmol Vis Sci. 2001;42:575-583.
13. Fischer AJ, McGuire JJ, Schaeffel F, Stell WK. Light- and focus-dependent expression of the transcription factor ZENK in the chick retina. Nat Neurosci. 1999;2:706-712.
14. Irving EL, Callender MG, Sivak JG. Inducing myopia, hyperopia, and astigmatism in chicks. Optometry Vision Sci. 1991;68:364-368.
15. Bolstad BM, Irizarry RA, Åstrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on bias and variance. Bioinformatics. 2003;19:185-193.
16. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001;98:5116-5121.
17. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-408.
18. http://www.ensembl.org/Gallus-gallus/index.html.
19. http://www.affymetrix.com/support/technical/datasheets/chicken-datasheet. pdf.
20. Fujisawa H, Okuno S. Review: Regulatory mechanism of tyrosine hydroxylase activity. Biochem Biopbys Res Commun. 2005;338:271-276.
21. Miyazono K, Maeda S, Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 2005;16:251-263.
22. Kishigami S, Mishina Y. BMP signaling and early embryonic patterning. Cytokine Growth Factor Rev. 2005;16:265-278.
23. You L, Kruse F, Pohl J, Völcker H. Bone morphogenetic proteins and growth and differentiation factors in the human cornea. Invest Ophthalmol Vis Sci. 1999;40:296-311.
24. Mathura JR Jr, Jafari N, Chang JT, et al. Bone morphogenetic proteins-2 and -4: negative growth regulators in adult retinal pigmented epithelium. Invest Ophthalmol Vis Sci. 2000;41:592-600.
25. Belecky-Adams T, Adler R. Developmental expression patterns of bone morphogenetic proteins, receptors, and binding proteins in the chick retina. J Comp Neurol. 2001;430:562-572.
26. Yang X-J. Roles of cell-extrinsic growth factors in vertebrate eye pattern formation and retinogenesis. Semin Cell Dev Biol. 2004;15:91-103.
27. Andreev K, Zenkel M, Kruse F, Jünemann A, Schlötzer-Schrehardt U. Expression of bone morphogenetic proteins (BMPs), their receptors, and activins in normal and scarred conjunctiva: role of BMP-6 and activin-A in conjunctival scarring? Exp Eye Res. 2006;83:1162-1170.
28. Brigstock DR. The CCN family: a new stimulus package. J Endocrinol. 2003;178:169-175.
29. Leask A, Abraham DJ. TGF-β signaling and the fibrotic response. FASEB J. 2004;18:816-827.
30. Rachfal AW, Brigstock DR. Structural and functional properties of CCN proteins. Vitam Horm. 2005;70:69-103.
31. Leask A, Abraham DJ. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol. 2003;81:355-363.
32. Rohrer B, Stell WK. Basic fibroblast growth factor (bFGF) and transforming growth factor beta (TGF-beta) act as stop and go signals to modulate postnatal ocular growth in the chick. Exp Eye Res. 1994;58:553-561.
33. Kuiper EJ, de Smet MD, van Meurs JC, et al. Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye. Arch Ophthalmol. 2006;124:1457-1462.
34. Chudgar SM, Deng P, Maddala R, Epstein DL, Rao PV. Regulation of connective tissue growth factor expression in the aqueous humor outflow pathway. Mol Vis. 2006;12:1117-1126.
35. Kiyama H, Katayama-Kumoi Y, Kimmel J, et al. Three dimensional analysis of retinal neuropeptides and amine in the chick. Brain Res Bull. 1985;15:155-165.
36. Pickett Seltner RL, Stell WK. The effect of vasoactive intestinal peptide on development of form deprivation myopia in the chick: a pharmacological and immunocytochemical study. Vision Res. 1995;35:1265-1270.
37. Vessey KA, Rushforth DA, Stell WK. Glucagon- and secretin-related peptides differentially alter ocular growth and the development of form-deprivation myopia in chicks. Invest Ophthalmol Vis Sci. 2005;46:3932-3942.
38. Stone RA, Laties AM, Raviola E, Wiesel TN. Increase in retinal vasoactive intestinal polypeptide after eyelid fusion in primates. Proc Natl Acad Sci USA. 1988;85:257-260.
39. Tkatchenko AV, Walsh PA, Tkatchenko TV, Gustincich S, Raviola E. Form deprivation modulates retinal neurogenesis in primate experimental myopia. Proc Natl Acad Sci USA. 2006;103:4681-4686.
40. Moody TW, Hill JM, Jensen RT. Review: VIP as a trophic factor in the CNS and cancer cells. Peptides. 2003;24:163-177.
41. c-src to melanogenesis and development of fluid transport capacity. Prog Retin Eye Res. 2000;19:669-688.
42. Sugo T, Murakami Y, Shimomura Y, et al. Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. Biochem Biophys Res Commun. 2003;310:860-868.
43. Mori M, Fujino M. Urotensin II-related pepetide, the endogenous ligand for the urotensin II receptor in the rat brain. Peptides. 2004;25:1815-1818.
44. Egginger J-G, Calas A. A novel hypothalamic neuroendocrine peptide: URP (urotensin-II-related peptide)? C R Biologies. 2005;328:724-731.
45. Nothacker H-P, Clark S. From heart to mind: the urotensin II system and its evolving neurophysiological role. FASEB J. 2005;272:5694-5702.
46. Douglas SA, Dhanak D, Johns DG. From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function. Trends Pharmacol Sci. 2004;25:76-85.
47. Onan D, Hannan RD, Thomas WG. Urotensin II: the old kid in town. Trends Endocrinol Metab. 2004;15:175-182.
48. Hunley TE, Kon V. Update on endothelins: biology and clinical implications. Pediatr Nephrol. 2001;16:752-762.
49. Kedzierski RM, Yanagisawa. Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol. 2001;41:851-876.
50. Lahav R. Endothelin receptor B is required for the expansion of melanocyte precursors and malignant melanoma. Int J Dev Biol. 2005;49:173-180.
51. Rattner A, Nathans J. The genomic response to retinal disease and injury: evidence for endothelin signaling from photoreceptors to glu. J Neurosci. 2005;25:4540-4549.
52. Gracie JA, Robertson SE, McInnes IB. Interleukin-18 J Leukoc Biol. 2003;73:213-224.
53. Cao R, Farnebo J, Kurimoto M, Cao Y. Interleukin-18 acts as an angiogenesis and tumor suppressor. FASEB J. 1999;13:2195-2202.
54. Felderhoff-Mueser U, Schmidt OI, Oberholzer A, Bührer C, Stahel PF. IL-18: a key player in neuroinflammation and neurodegeneration? Trends Neurosci. 2005;28:487-493.
55. McInnes IB, Liew FY, Gracie JA. Interleukin-18: a therapeutic target in rheumatoid arthritis? Arthritis Res Ther. 2005;7:38-41.
56. Jiang H-R, Wei X-q, Niedbala W, Lumsden L, Liew FY, Forrester JV. IL-18 not required for IRB peptide-induced EAU: studies in gene-deficient mice. Invest Ophthalmol Vis Sci. 2001;42:177-182.
57. Qiao H, Sonoda K-H, Sassa Y, et al. Abnormal retinal vascular development in IL-18 knockout mice. Lab Invest. 2004;84:973-980.
58. Farooq A, Zhou M-M. Structure and regulation of MAPK phosphatases. Cell Signal. 2004;16:769-779.
59. Sloss CM, Cadalbert L, Finn SG, Fuller SJ, Plevin R. Disruption of two putative nuclear localization sequences is required for cytosolic localization of mitogen-activated protein kinase phosphastase-2. Cell Signal. 2005;17:709-716.
60. Qi M, Elion EA. MAP kinase pathways. J Cell Sci. 2005;118:3569-3572.
61. Johnson GL, Dohlman HG, Graves LM. MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression. Curr Opin Chem Biol. 2005;9:325-331.
62. Imajo M, Tsuchiya Y, Nishida E. Critical review: regulatory mechanisms and function of MAP kinase signaling pathways. Life. 2006;58:312-317.
63. Fujii S, Escano MFT, Ishibashi K, et al. Differential expression of neuroendocrine-specific protein in form-deprived chick eyes. Invest Ophthalmol Vis Sci. 2000;41:1533-1541.
64. Feldkaemper MP, Wang H-Y, Schaeffel F. Changes in retinal and choroidal gene expression during development of refractive errors in chicks. Invest Ophthalmol Vis Sci. 2000;41:1623-1628.
65. Morgan I, Kucharski R, Krongkaew N, Firth SI, Megaw P, Maleszka R. Screening for differential gene expression during development of form-deprivation myopia in the chicken. Optom Vis Sci. 2004;81:148-155.
66. Ishibashi K, Fujii S, Escaño MFT, Sekiya Y, Yamamoto M. Up-regulation of crystallin mRNAs in form-deprived chick eyes. Exp Eye Res. 2000;70:153-158.
67. Fujii S, Honda S, Sekiya Y, Yamasaki M, Yamamoto M, Saijoh K. Differential expression of nitric oxide synthase isoforms in form-deprived chick eyes. Curr Eye Res. 1998;17:586-593.
68. Escano MFT, Fujii S, Sekiya Y, Yamamoto M, Negi A. Expression of sonic hedgehog and retinal opsin genes in experimentally-induced myopic chick eyes. Exp Eye Res. 2000;71:459-467.
69. Akamatsu S, Fujii S, Escaño MFT, Ishibashi K, Sekiya Y, Yamamoto M. Altered expression of genes in experimentally induced myopic chick eyes. Jpn J Ophthalmol. 2001;45:137-143.
70. Bertrand E, Fritsch C, Diether S, et al. Identification of apolipoprotein A-1 as a "STOP" signal for myopia. Mol Cell Proteomics. 2006;5:2158-2166.
71. Morgan I, Rose K. How genetic is school myopia? Prog Retin Eye Res. 2005;24:1-38.
72. Gwiazda J, Thorn F, Bauer J, Held R. Emmetropization and the progression of manifest refraction in children followed from infancy to puberty. Clin Vision Sci. 1993;8:337-344.